VS38 Identifies Myeloma Cells With Dim CD38 Expression and Plasma Cells Following Daratumumab Therapy, Which Interferes With CD38 Detection for 4 to 6 Months
Article in American Journal of Clinical Pathology (November 2019)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in American Journal of Clinical Pathology (November 2019)
Article in International Journal of Hematology (June 2019)